Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Study Says
Bloomberg Businessweek
Wed, 12/7/11 - 11:05 am
prostate cancer
AstraZeneca
Watson
Lupron
Abbott Laboratories
Vantas
Trelstar
Zoladex
Endo
A Trading Strategy For 7 Biotech/Healthcare Stocks With Upcoming PDUFA Date
Seeking Alpha
Tue, 12/6/11 - 09:21 am
Alkermes
Amylin
Antares
AstraZeneca
Bristol-Myers Squibb
Merck
Eli Lilly
AZ opens drug portfolio to academic investigators
Fierce Biotech
Mon, 12/5/11 - 01:32 pm
AstraZeneca
Teva v. Astrazeneca: Invalidating a patent with secret prior art
Patently
Fri, 12/2/11 - 12:08 pm
Teva Pharmaceuticals
AstraZeneca
patents
AZ bolsters VC arm with $100 million, buys into Australian firm
Pharma Times, UK
Tue, 11/29/11 - 08:22 am
venture capital
AstraZeneca
Australia
NeuProject
MedImmune Ventures
AstraZeneca Victory Over Iressa Labeling Is Appealed
Pharmalot
Mon, 11/28/11 - 09:57 am
AstraZeneca
Iressa
lung cancer
AstraZeneca: Dirt Cheap Pharmaceutical Stock With A 6% Yield And Strong Technical Support
Seeking Alpha
Sat, 11/26/11 - 10:37 am
AstraZeneca
AstraZeneca Releases Full SATURN Data
Yahoo/Zacks
Sat, 11/19/11 - 12:32 pm
Pfizer
Lipitor
Crestor
atherosclerosis
AstraZeneca
SATURN
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Seeking Alpha
Fri, 11/18/11 - 11:42 am
Intellipharmaceutics
generics
Pfizer
AstraZeneca
Novartis
Bristol-Myers Squibb
AstraZeneca: Saturn Trial Will Hamper Revenue Growth
Seeking Alpha
Fri, 11/18/11 - 11:40 am
SATURN
Pfizer
AstraZeneca
Crestor
Lipitor
statins
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Motley Fool
Fri, 11/18/11 - 11:39 am
EMA
AstraZeneca
medullary thyroid cancer
vandetanib
AstraZeneca’s Crestor Fails to Beat Lipitor
Bloomberg
Tue, 11/15/11 - 12:57 pm
Crestor
statins
Lipitor
AstraZeneca
Pfizer
AstraZeneca says new antidepressant not ready for pharmaceutical sales in U.S.
medreps
Sat, 11/12/11 - 12:57 pm
TC-5214
AstraZeneca
antidepressants
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb
Targacept Depression Drug Fails Late-Stage Study
TheStreet.com
Tue, 11/8/11 - 10:32 am
depression
Targacept
AstraZeneca
TC-5214
Endo gets OK for generic of AstraZeneca blood pressure drug
Bizjournals.com
Wed, 11/2/11 - 11:21 am
Qualitest
Plendil
generics
Endo
AstraZeneca
antihypertensives
Ranking Drug Company Dividend Stocks By Risk And Growth
Seeking Alpha
Tue, 11/1/11 - 06:14 pm
dividends
JNJ
Pfizer
Novartis
GSK
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
AstraZeneca Q3 net profit boosted by disposal
Yahoo/AP
Thu, 10/27/11 - 09:29 am
earnings
AstraZeneca
Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wed, 10/26/11 - 06:12 pm
Bristol-Myers Squibb
diabetes
FDA
AstraZeneca
Dapagliflozin
10 largest upcoming pharma patent losses in the US
Fierce Pharma
Tue, 10/25/11 - 11:54 am
Takeda
Actos
Forest Labs
Lexapro
Bristol-Myers Squibb
Plavix
AstraZeneca
Seroquel
Eli Lilly
Zyprexa
Pfizer
Lipitor
Merck
Singulair
Novartis
Diovan
Provigil
Teva Pharmaceuticals
Abbott Laboratories
TriCor
Pages
« first
‹ previous
…
129
130
131
132
133
134
135
136
137
…
next ›
last »